DD21593A - - Google Patents
Info
- Publication number
- DD21593A DD21593A DD21593DA DD21593A DD 21593 A DD21593 A DD 21593A DD 21593D A DD21593D A DD 21593DA DD 21593 A DD21593 A DD 21593A
- Authority
- DD
- German Democratic Republic
Links
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD21593A true DD21593A (pt) |
Family
ID=231508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD21593D DD21593A (pt) |
Country Status (1)
| Country | Link |
|---|---|
| DD (1) | DD21593A (pt) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4232155A (en) * | 1979-09-13 | 1980-11-04 | Bristol-Myers Company | Purine compounds |
| WO2006045828A1 (en) * | 2004-10-29 | 2006-05-04 | Tibotec Pharmaceuticals Ltd. | Hiv inhibiting bicyclic pyrimidine derivatives |
| CN103936742B (zh) * | 2013-01-17 | 2017-05-03 | 程鹏 | 含嘌呤基的新型pi3k抑制剂及其制备方法和应用 |
-
0
- DD DD21593D patent/DD21593A/xx unknown
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4232155A (en) * | 1979-09-13 | 1980-11-04 | Bristol-Myers Company | Purine compounds |
| WO2006045828A1 (en) * | 2004-10-29 | 2006-05-04 | Tibotec Pharmaceuticals Ltd. | Hiv inhibiting bicyclic pyrimidine derivatives |
| JP2008517978A (ja) * | 2004-10-29 | 2008-05-29 | テイボテク・フアーマシユーチカルズ・リミテツド | Ｈｉｖ阻害性二環式ピリミジン誘導体 |
| RU2403254C2 (ru) * | 2004-10-29 | 2010-11-10 | Тиботек Фармасьютикалз Лтд. | Бициклические производные пиримидина, ингибирующие вич |
| AU2005298637B2 (en) * | 2004-10-29 | 2012-06-28 | Janssen Sciences Ireland Uc | HIV inhibiting bicyclic pyrimidine derivatives |
| AU2005298637A8 (en) * | 2004-10-29 | 2012-12-06 | Janssen Sciences Ireland Uc | HIV inhibiting bicyclic pyrimidine derivatives |
| AU2005298637B8 (en) * | 2004-10-29 | 2012-12-06 | Janssen Sciences Ireland Uc | HIV inhibiting bicyclic pyrimidine derivatives |
| US10077270B2 (en) | 2004-10-29 | 2018-09-18 | Janssen Sciences Ireland Uc | HIV inhibiting bicyclic pyrimidine derivatives |
| CN103936742B (zh) * | 2013-01-17 | 2017-05-03 | 程鹏 | 含嘌呤基的新型pi3k抑制剂及其制备方法和应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10077270B2 (en) | HIV inhibiting bicyclic pyrimidine derivatives | |
| US20210253578A1 (en) | Pyrrolopyrimidine compounds and their uses | |
| EP3497087A1 (en) | Certain chemical entities, compositions, and methods | |
| WO2016105532A1 (en) | Fused pyrimidine compounds for the treatment of hiv | |
| WO2014124230A3 (en) | Erk inhibitors and uses thereof | |
| ES2744198T3 (es) | Formulaciones farmacéuticas, procesos, formas sólidas y procedimientos de uso relacionados con 1-etil-7-(2-metil-6-(1H-1,2,4-triazol-3-il)piridin-3-il)-3, 4 dihidropirazino[2,3-b]pirazin-2(1H)-ona | |
| EE200000535A (et) | Triasendatud 1,3,5-triasiini derivaatide kasutamine ravimi valmistamiseks, mis on ette nähtud HIV nakkuse raviks, ühend, seda sisaldav farmatseutiline kompositsioon, meetod ühendi ja kompositsiooni valmistamiseks ning kombineeritud preparaat kasutami | |
| MX2022007265A (es) | Compuestos activos frente a receptores nucleares. | |
| EP3020829B1 (en) | Pharmaceutical composition capable of inhibiting abnormal splicing causative of onset or progress of a genetic disease | |
| US4232155A (en) | Purine compounds | |
| CN103936742A (zh) | 含嘌呤基的新型pi3k抑制剂及其制备方法和应用 | |
| WO2011079704A1 (zh) | （e）-3-（3-取代-5-甲基苯基）丙烯腈及其制备方法 |